Our focus and developments

At Thelial Technologies SA we focus on biological barriers. Using our patented platform technology we have discovered a set of candidate compounds. The first product, targeting esophagus health, was launched by Epinutra (www.epinutra.com) in Q4 2020.

In March 2020 we moved to new offices at